Skip to menu Skip to content Skip to footer
Professor Kwun Fong
Professor

Kwun Fong

Email: 

Overview

Background

Kwun is a Thoracic and Sleep Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre (UQTRC). His research interests are focussed on making and translating research discoveries to improving outcomes and the health of people who are affected by lung disease particularly lung cancer screening/early detection and biomarkers. The UQTRC is also passionate at enabling productive collaborations to maximise research impact and scale with contributions to The Cancer Genome Atlas Project, Pan-Cancer Analysis of Whole Genomes (PCAWG), IASLC Lung Cancer Staging Project and others.

Availability

Professor Kwun Fong is:
Available for supervision

Research impacts

Lung cancer is the leading cause of cancer mortality in Australia and globally. The prevention, early detection/screening and optimal management of lung cancer will help address the huge burden from lung cancer, enabled by high impact research and addressing stigma and nihilism and the health disparities that exist.

The team at The Prince Charles Hospital and University of Queensland Thoracic Research Centre are passionate, focussed and internationally recognised, leading clinical research in lung cancer in Australia. They are very pleased and privileged to work with patients, families / carers and consumers to make a difference in this awful disease.

Works

Search Professor Kwun Fong’s works on UQ eSpace

438 works between 1986 and 2025

341 - 360 of 438 works

2006

Other Outputs

Tumors, Malignant: Bronchogenic Carcinoma

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Bronchogenic Carcinoma.

Tumors, Malignant: Bronchogenic Carcinoma

2006

Book Chapter

TUMORS, MALIGNANT | Metastases from Lung Cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). TUMORS, MALIGNANT | Metastases from Lung Cancer. Encyclopedia of Respiratory Medicine: Volume 1-4. (pp. V4-350-V4-356) Elsevier. doi: 10.1016/B0-12-370879-6/00412-9

TUMORS, MALIGNANT | Metastases from Lung Cancer

2006

Other Outputs

Tumors, Malignant: Overview

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Overview.

Tumors, Malignant: Overview

2006

Book Chapter

Tumors, malignant: bronchogenic carcinoma

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, malignant: bronchogenic carcinoma. Encyclopedia of respiratory medicine. (pp. 325-332) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00408-7

Tumors, malignant: bronchogenic carcinoma

2006

Conference Publication

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

Molenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC.

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

2006

Journal Article

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2006). CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27 (3), 525-532. doi: 10.1093/carcin/bgi227

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

2006

Journal Article

Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland

Coory, M., Fong, K., Bowman, R. and Hall, L. (2006). Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland. Internal Medicine Journal, 36 (6), 389-392. doi: 10.1111/j.1445-5994.2006.01074.x

Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland

2005

Journal Article

Cochrane systematic reviews of treatments for lung cancer

Fong, K. M., Yang, I .A., Zimmerman, P. V. and Bowman, R. V. (2005). Cochrane systematic reviews of treatments for lung cancer. Respiratory Medicine, 99 (9), 1071-1078. doi: 10.1016/j.rmed.2005.05.002

Cochrane systematic reviews of treatments for lung cancer

2005

Journal Article

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation

Zochbauer-Muller, Sabine, Fong, Kwun M., Geradts, Joseph, Xu, Xie, Seidl, Sonja, End-Pfützenreuter, Adelheid, Lang, György, Heller, Gerwin, Zielinski, Christoph C., Gazdar, Adi F. and Minna, John D. (2005). Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene, 24 (41), 6249-6255. doi: 10.1038/sj.onc.1208775

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation

2005

Journal Article

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2005). Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes and Control, 16 (5), 579-585. doi: 10.1007/s10552-004-7842-3

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

2005

Journal Article

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

Tothill, R.W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., van Laar, R.K., Waring, P.M., Zalcberg, J., Ward, R., Biankin, A.V., Sutherland, R.L., Henshall, S.M., Fong, K., Pollack, J.R., Bowtell, D.D.L. and Holloway, A.J. (2005). An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research, 65 (10), 4031-4040. doi: 10.1158/0008-5472.CAN-04-3617

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

2005

Journal Article

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Shigematsu, Hisayuki, Lin, Li, Takahashi, Takao, Nomura, Masaharu, Suzuki, Makoto, Wistuba, Ignacio I., Fong, Kwun M., Lee, Huei, Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Feng, Ziding, Roth, Jack A., Herz, Joachim, Minna, John, D. and Gazdar, Adi, F. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Journal of the National Cancer Institute, 97 (5), 339-346. doi: 10.1093/jnci/dji055

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

2005

Journal Article

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Shigematsu, Hisayuki, Takahashi, Takao, Nomura, Masaharu, Majmudar,Kuntal, Suzuki, Makoto, Lee, Huei, Wistuba, Ignacio I., Fong, Kwun M., Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Minna, John D. and Gazdar, Adi F. (2005). Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Research, 65 (5), 1642-1646. doi: 10.1158/0008-5472.CAN-04-4235

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

2005

Other Outputs

Molecular Biology of Lung Cancer

Sekido, Y., Fong, K M. and Minna, J. D. (2005). Molecular Biology of Lung Cancer.

Molecular Biology of Lung Cancer

2005

Conference Publication

Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003

Fong, K., Bowman, R., Abraham, R., Windsor, M., Pratt, G., Fielding, D., Armstrong, J. and Zimmerman, P. (2005). Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003. 11th World Conference on Lung Cancer, Barcelona, Spain, 3–6 July, 2005. Shannon, Co. Clare, Ireland: Elsevier Science. doi: 10.1016/S0169-5002(05)80820-7

Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003

2005

Conference Publication

Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokers

Bowman, R., Maclachlan, R., Clarke, B., Duhig, E. and Fong, K. (2005). Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokers. 11th World Conference on Lung Cancer, Barcelona, Spain, 3rd – 6 July, 2005. CLARE: ELSEVIER IRELAND LTD. doi: 10.1016/S0169-5002(05)80385-X

Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokers

2005

Conference Publication

P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epithelium

Bowman, R., MacLachlan, R., Clarke, B., Duhig, E., Davidson, M. and Fong, K. (2005). P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epithelium. Abstract of the 11th World Conference on Lung Cancer, Barcelona, Spain, 3–6 July 2005. Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80733-0

P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epithelium

2005

Conference Publication

Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomas

Larsen, J., Pavey, S., Passmore, L., Bowman, R., Hayward, N., Zimmerman, P. and Fong, K. (2005). Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomas. 11th World Conference on Lung Cancer, Barcelona, Spain, 03-06 July 2005. Shannon, Co. Clare, Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80568-9

Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomas

2005

Journal Article

Effectiveness of hospital-based smoking cessation

Fung, Pamela R., Snape-Jenkinson, Stella L., Godfrey, Maureen T., Love, Keith W., Zimmerman, Paul V., Yang, Ian A. and Fong, Kwun M. (2005). Effectiveness of hospital-based smoking cessation. Chest, 128 (1), 216-223. doi: 10.1378/chest.128.1.216

Effectiveness of hospital-based smoking cessation

2005

Conference Publication

Expression profiling of metastatic recurrence in primary bronchogenic squamous cell

Larsen, J., Pavey, S., Passmore, L., Bowman, R., Hayward, N., Zimmerman, P. and Fong, K. (2005). Expression profiling of metastatic recurrence in primary bronchogenic squamous cell. 11th World Conference on Lung Cancer 2005, Barcelona, Spain, 3-6 July 2005. Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80568-9

Expression profiling of metastatic recurrence in primary bronchogenic squamous cell

Funding

Current funding

  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant

Supervision

Availability

Professor Kwun Fong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Principal Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Principal Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Combined Compressed sensing and machine learning/deep learning methods for rapid MRI

    Associate Advisor

    Other advisors: Associate Professor Henry Marshall, Dr Hongfu Sun, Professor Feng Liu

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Associate Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Effectiveness of Non-invasive Ventilation for the treatment of nocturnal hypoventilation in Myotonic Dystrophy

    Associate Advisor

    Other advisors: Professor Elizabeth Coulson

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture and low bone density in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Doctor Philosophy

    Biomarkers of lung cancer

    Associate Advisor

    Other advisors: Professor Ian Yang

Completed supervision

Media

Enquiries

For media enquiries about Professor Kwun Fong's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au